Pau d'arco hair loss remedies have gained attention online, but what does the evidence actually show? Pau d'arco is a South American tree bark used in traditional herbal medicine, containing compounds such as lapachol that have been studied for antifungal and anti-inflammatory properties. Some proponents suggest it may support scalp health and reduce hair shedding, yet no clinical trials have evaluated its effectiveness for hair loss in humans. This article examines the available evidence, safety considerations, and NHS-recommended alternatives, helping you make an informed decision before trying any herbal supplement.

What Is Pau D'Arco and How Is It Used?

Pau d'arco is a South American tree bark used in traditional medicine and sold in the UK as an unlicensed food supplement in teas, capsules, tinctures, and topical preparations. It has no UK Traditional Herbal Registration and is not regulated by the MHRA.

Pau d'arco — botanically known as Handroanthus impetiginosus (syn. Tabebuia impetiginosa) — is a tree native to South America, particularly the rainforests of Brazil and Argentina. Its inner bark has been used for centuries in traditional medicine by indigenous communities to treat a wide range of conditions, including infections, inflammation, and skin disorders. The bark contains active compounds — most notably lapachol and beta-lapachone — which have been investigated in laboratory settings for potential antifungal, antibacterial, and anti-inflammatory activity, though the clinical significance of these findings in humans remains unestablished.

In contemporary herbal medicine, pau d'arco is available in several forms, including:

• Teas and infusions brewed from dried bark

• Tinctures and liquid extracts

• Capsules and tablets sold as dietary supplements

• Topical preparations, occasionally included in shampoos or scalp treatments

Some proponents suggest that pau d'arco may support hair health by addressing scalp conditions such as fungal infections or inflammation, which can sometimes contribute to hair thinning. However, it is important to note that pau d'arco has no UK Traditional Herbal Registration (THR) and is not a licensed medicine in the UK. Products are sold as food supplements, regulated under food law by the Food Standards Agency (FSA) and Trading Standards, rather than as medicines overseen by the Medicines and Healthcare products Regulatory Agency (MHRA). This means they are not subject to pre-market assessment of efficacy or safety, and the quality and composition of products can vary substantially between manufacturers. Consumers should approach such products with appropriate caution and realistic expectations.

What the Evidence Says About Herbal Remedies and Hair Loss

There is no robust clinical evidence supporting pau d'arco for hair loss; no human trials exist, and NICE does not recommend any herbal supplement for alopecia. Laboratory antifungal findings have not been translated into proven clinical benefit.

Not sure if this is normal? Chat with one of our pharmacists →

Hair loss — medically termed alopecia — has numerous causes, including androgenetic alopecia (male and female pattern baldness), alopecia areata (an autoimmune condition), telogen effluvium (stress- or illness-related shedding), and scalp infections such as tinea capitis. Each cause requires a different approach to management, and no single herbal remedy addresses all of them.

With specific regard to pau d'arco and hair loss, there is currently no robust clinical evidence to support its use as a treatment. No peer-reviewed clinical trials have evaluated pau d'arco's efficacy for promoting hair growth or reducing hair loss in humans. Some laboratory studies have explored the antifungal properties of lapachol, which could theoretically be relevant in cases where scalp fungal infections contribute to hair shedding — but translating in vitro findings to clinical benefit requires rigorous human trials that do not yet exist.

More broadly, the evidence base for herbal remedies in hair loss is limited. A small number of studies have examined preparations such as rosemary oil and saw palmetto, with modest and inconsistent results. The National Institute for Health and Care Excellence (NICE) does not currently recommend any herbal supplement for the treatment of hair loss, whether androgenetic alopecia or alopecia areata. It is also worth noting that micronutrient supplements — such as biotin or zinc — are only likely to be of benefit where a confirmed deficiency has been identified; routine supplementation without evidence of deficiency is not supported by current UK guidance.

Patients should be aware that:

• Anecdotal reports are not a substitute for clinical evidence

• Supplement quality varies considerably between manufacturers

• Interactions with prescribed medications are possible

In the absence of reliable evidence, individuals considering pau d'arco for hair loss should discuss this with a qualified healthcare professional before use.

Safety Considerations and Potential Side Effects

Pau d'arco can cause nausea, vomiting, increased bleeding risk, and potential haemolytic effects at high doses, and should be avoided alongside anticoagulants. It is not recommended in pregnancy, breastfeeding, children, or those with liver or kidney conditions.

Although pau d'arco is a naturally derived product, 'natural' does not automatically mean safe. Several safety concerns have been identified in relation to its use, and these are particularly relevant when pau d'arco is consumed in high doses or over prolonged periods.

The active compound lapachol has been associated with adverse effects, particularly at higher doses, including:

Experiencing these side effects? Our pharmacists can help you navigate them →

• Nausea, vomiting, and diarrhoea

• Increased bleeding risk — pau d'arco and lapachol have been associated with increased bleeding risk, though the precise mechanism is not fully established. Use alongside anticoagulants (such as warfarin or direct oral anticoagulants [DOACs]), antiplatelet agents, or other medicines that affect bleeding should be avoided unless specifically advised by a clinician.

• Anaemia — some high-dose animal studies and limited human data have suggested possible haemolytic effects, though this has not been robustly established in clinical settings at typical supplement doses.

Pau d'arco is not recommended for the following groups without prior medical advice:

• Pregnant or breastfeeding women — safety in pregnancy and breastfeeding has not been established and use should be avoided

• Individuals taking blood-thinning medications (anticoagulants, antiplatelets)

• Those with liver or kidney conditions

• Children

The MHRA has not approved pau d'arco as a medicinal product in the UK, and it is not subject to pre-market safety assessments in the same way as licensed medicines. If you experience any unexpected symptoms after taking pau d'arco — such as unusual bruising or bleeding, gastrointestinal upset, or skin reactions — you should stop use and seek medical advice promptly. Suspected adverse reactions to supplements can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

NHS-Recommended Treatments for Hair Loss in the UK

NHS-recommended treatments include topical minoxidil for pattern hair loss, prescription finasteride for men, corticosteroids or baricitinib for alopecia areata, and oral antifungals for scalp infections. The appropriate treatment depends on accurate diagnosis of the underlying cause.

For those experiencing hair loss, the NHS and NICE provide guidance on evidence-based treatments that have been evaluated through clinical trials and regulatory review. The appropriate treatment depends on the underlying cause of hair loss, which is why accurate diagnosis is essential before beginning any intervention.

For androgenetic alopecia (pattern hair loss):

• Minoxidil (available over the counter as a topical solution or foam) is the most widely used treatment for both men and women. It prolongs the anagen (growth) phase of the hair cycle and is supported by good-quality clinical evidence. Treatment must be continued long term, as any benefit is typically lost if it is stopped.

• Finasteride (prescription only, for men) works by inhibiting 5-alpha reductase, reducing the conversion of testosterone to dihydrotestosterone (DHT), which is implicated in follicle miniaturisation. As with minoxidil, ongoing use is required to maintain benefit. Important safety note: finasteride is teratogenic and must not be used by women who are pregnant or who may become pregnant; such women should also avoid handling crushed or broken tablets. Prescribers and patients should refer to the current Summary of Product Characteristics (SmPC) on the electronic Medicines Compendium (emc) for full safety information.

For alopecia areata:

• Topical, intralesional, or systemic corticosteroids may be used to suppress the autoimmune response.

• The JAK inhibitor baricitinib has received MHRA marketing authorisation and a NICE Technology Appraisal recommendation for the treatment of severe alopecia areata in adults who meet the specified eligibility criteria. Prescribing is specialist-led, and patients should be assessed and monitored by a consultant dermatologist in line with the NICE guidance.

For scalp infections (e.g., tinea capitis):

• Oral antifungal agents such as terbinafine or griseofulvin are the standard of care; topical treatments alone are insufficient.

It is worth noting that many hair loss conditions are self-limiting or manageable with appropriate treatment. The NHS also signposts patients to psychological support where hair loss is causing significant distress, recognising the considerable impact it can have on mental wellbeing. Patients are encouraged to seek evidence-based care rather than relying on unproven supplements.

When to Speak to a GP or Dermatologist

You should see a GP if you experience sudden, patchy, or worsening hair loss, especially with scalp symptoms or systemic signs such as fatigue or hormonal changes. Scarring alopecia or suspected tinea capitis requires prompt specialist assessment to prevent permanent follicle loss.

Hair loss can be a distressing experience, and whilst some degree of daily shedding (typically 50–100 hairs per day) is entirely normal, certain patterns or associated symptoms warrant professional evaluation. Seeking timely medical advice ensures that any underlying cause is identified and managed appropriately — and prevents unnecessary delay in accessing effective treatment.

You should contact your GP if you notice:

• Sudden or rapid hair loss, particularly in patches

• Diffuse thinning across the scalp that is worsening over time

• Hair loss accompanied by scalp redness, scaling, itching, or pain

• Hair loss alongside other symptoms such as fatigue, weight changes, or irregular periods (which may suggest a thyroid disorder or hormonal imbalance)

• Hair loss following a significant illness, surgery, or period of high stress

• Eyebrow, eyelash, or body hair loss in addition to scalp hair

Urgent red flags — seek prompt assessment if you notice:

• Scarring, perifollicular redness or scaling, pustules, or significant scalp pain or tenderness, which may indicate a scarring (cicatricial) alopecia requiring urgent specialist evaluation to prevent permanent follicle loss

• Suspected tinea capitis (ringworm of the scalp), particularly in children, which requires prompt systemic antifungal treatment

Your GP may arrange targeted blood tests in line with NICE guidance — typically including a full blood count (FBC), ferritin, and thyroid-stimulating hormone (TSH). In women with features suggestive of hyperandrogenism (such as irregular periods, acne, or hirsutism), hormonal investigations may also be appropriate. Routine vitamin D testing is not currently recommended in UK guidance for hair loss unless there is a specific clinical indication. If the diagnosis is unclear or the condition is not responding to initial treatment, referral to a consultant dermatologist may be appropriate.

Regarding pau d'arco specifically — if you are already using or considering this supplement, it is important to inform your GP or pharmacist, particularly if you are taking any prescribed medications. There is no established evidence linking pau d'arco to effective hair loss treatment, and a healthcare professional can help you weigh up the limited evidence against potential risks, and guide you towards treatments with a stronger evidence base.

Frequently Asked Questions